

OncoImmune Inc, a biopharmaceutical company, has raised $56 million in Series B funding. The investors include HM Capital, 3E Bioventures Capital, Kaitai Capital, GBA Fund and GF Xinde.
Source: Press Release
OncoImmune Inc, a biopharmaceutical company, has raised $56 million in Series B funding.
OncoImmune Inc, a biopharmaceutical company, has raised $56 million in Series B funding. The investors include HM Capital, 3E Bioventures Capital, Kaitai Capital, GBA Fund and GF Xinde.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination